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ABSTRACT 
Objectives: Urinary tract infection (UTIs) caused by Citrobacter species have been described in 5 to 12% of bacterial urine isolates in adults. The 
genus Citrobacter is a distinct group of aerobic Gram-negative bacilli from the Enterobacteriaceae family. We report here the emergence of 
Citrobacter as an increasingly common urinary pathogen in patients attending this medical college. 
Methods: The study was carried out over a period of 2 years from January 2010 to December 2011. Urine specimens from both outpatients and 
inpatients of our hospital were processed. Urine samples which yielded the growth Citrobacter spp. were included in the study  
Results: E. coli was the most common organism isolated followed by Klebsiella spp. and Citrobacter spp. The most active antimicrobial agent against 
Citrobacter isolates was piperacillin-tazobactum (55% sensitive), closely followed by amikacin (47%). 
Conclusion: The emergence of this usually rare organism as the third most common urinary pathogen, which is resistant to commonly available 
antibiotics is alarming. Such studies will guide clinicians to choose accurate empirical treatment options and will help to reduce the mortality and 
morbidity rates from infections.  
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INTRODUCTION 
Urinary tract infection (UTI) continues to be the commonest 
nosocomial infection according for approximately 40% of all hospital 
acquired infections and it is one of the most important causes of 
morbidity and mortality [1, 2]. UTIs caused by Citrobacter species have 
been described in 5 to 12% of bacterial urine isolates in adults [3].  
The genus Citrobacter is a distinct group of aerobic Gram-negative 
bacilli from the Enterobacteriaceae family [4]. Citrobacter species are 
primary inhabitants of intestinal tract, often found in human feces [5]. 
They are also found in soil, sewage, food, and animal feces [6, 7].  
These organisms are isolated from variety of clinical specimens like 
urine, pus, blood, and cerebrospinal fluid [8]. Organisms of genus 
Citrobacter are Gram-negative straight rods, found singly or in pairs, 
and are motile by peritrichous flagellae. They are facultative 
anaerobes, oxidase-negative, and typically utilize citrate as sole source 
of carbon. The genus Citrobacter comprises 11 different species. 
Among these, Citrobacter koseri (previously known as C. diversus) and 
C. freundii are the commonest species implicated in infections. 
Citrobacter species can cause variety of infections like, respiratory 
tract infections, urinary tract infection, blood stream infections, wound 
and burns infections, meningitis, endocarditis, and peritonitis [9]. We 
report here the emergence of Citrobacter as an increasingly common 
urinary pathogen in patients attending this medical college. 
MATERIALS AND METHODS 
Study population, design, and setting 
The current study was conducted in the Department of 
Microbiology, Shri B M Patil Medical College, Bijapur, from January 
2010 to December 2011. 
Ethical clearance and consent 
As it was a retrospective study, ethical clearance and consent was 
not obtained. 
Patient evaluation 
A total of 1434 urine specimens from both outpatients and 
inpatients of our hospital having one or more urinary symptoms, 
like burning during micturition, fever, pyuria, frequency of urine, 
dysuria, hematuria, flank pain, suprapubic discomfort, etc., were 
processed. 
Sample collection and isolation, identification of the organism 
Mid-stream urine sample in early morning was collected in wide 
mouth sterile container [10]. All urine samples were examined by 
routine microscopic examination by wet mount of urine sediment 
after centrifuging urine for 10 minutes at 1000 revolution per 
minute (rpm).  
Presence of pus cells, red blood cells (RBCs), epithelial cells, casts, 
and crystals were noted as supportive findings of urinary infection. 
Simultaneously all urine samples were cultured over routine culture 
media; Mac Conkey agar and Cysteine lactose electrolyte deficient 
(CLED) agar with a sterile standard loop. These plates were 
incubated at 37°C for 2 consecutive days.  
Culture results were interpreted according to the standard criteria 
and a growth of ≥10 5
Antimicrobial susceptibility testing 
 colony forming units/ml was considered as 
significant bacteriuria [11][11]. Cultures with more than three 
colonies were discarded, as contaminants and their antibiotic 
susceptibility were not tested. Species were identified by 
conventional biochemical tests according to standard 
microbiological techniques [10]. 
All isolates were tested for antimicrobial susceptibility on Mueller 
Hinton agar by the standard disc diffusion method recommended by 
the Clinical and Laboratory Standards Institute (CLSI)[12]. agents 
(disks) were obtained from Hi Media laboratories, Pvt Ltd, Mumbai. 
Appropriate quality control strains were used to validate the results 
of the antimicrobial disk. E. coli, ATCC 25922, and Pseudomonas 
aeruginosa, ATCC 27853, were used as quality control strains [12]. 
Statistical analysis 
Statistical analysis was performed with SPSS 14 software. 
Categorical data was analyzed using Chi-Square test with a 0.05 
significance level. 
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RESULTS AND DISCUSSION 
The education and application of personal hygiene are important in 
that Citrobacter strains are excreted as fecal wastes. Epidemics 
occurring in hospitals are closely related to the fact that hospital 
staff carry the bacterium in their hands and gastrointestinal systems. 
Citrobacter strains are mostly isolated from the infections of urinary 
and respiratory systems as nosocomial infection causes [13]. 
Urinary tract infection by C. koseri has been reported to be 12.0% in 
1969 and the prevalence rate is rising. Invasive procedures like, 
catheterization helps them to colonize urinary bladder and during 
intensive chemotherapy this bacterium disseminates to the blood 
stream to cause severe bacteremia. Intact immunity helps to control 
the pathogen to certain extent but when the patients are 
immunocompromised, the situation is grave. The problem is further 
intensified by the emergence of multidrug resistance Citrobacter sp. 
resulting into treatment failure [14]. 
In the present study, Citrobacter infections were high among elderly 
people; this is because of the fact that these groups constitute large 
proportion of our hospital populations and reduced immunity in 
these people to fight against infection in general. Similar results 
were seen in the study conducted by Shih et al [15]. 
In this study piperacillin-tazobactum was the most active drug, 
closely followed amikacin. Least active antibiotics were ampicillin 
and amoxyclav. Amoxycillin and ampicillin are often used as oral 
therapy for gram –negative UTIs, but the high rate of in vitro 
resistance demonstrated in this study and others suggests that they 
should not be used. Trimethoprim and amoxyclav are also often 
prescribed; of concern is the increasing rate of resistance to 
trimethoprim over the last 10 years and the more recent increase in 
resistance to amoxyclav, presumably as a result of mechanisms 
other than production of beta –lactamase [16]. 
 
Table 1: Frequency of different organism isolated from UTI 
Organism  Number  Percentage  
E. coli  314 45.6 
Klebsiella spp. 124 17.9 
Citrobacter spp. 108 15.7 
Other Gram negatives bacilli 38 5.5 
Gram positive cocci 61 8.9 
Fungi 44 6,4 
Total  689 100 
Of the 1434 urine samples received for culture during the study 
period, 12 samples contained more than one species, significant 
bacteriuria was found in 48.1 % samples. Among these E. coli was 
the most common organism isolated (Table 1) followed by Klebsiella 
spp. and Citrobacter spp. 
  
Table 2: Age and sex wise distribution of Citrobacter spp from UTI patients 






 Number % Number % Number % 
1-20 6 8.1 4 10.8 10 9.26 
21-50 24 35.1 23 62.2 47 43.5 
> 51 41 57.7 10 27.0 51 47.2 
In all age groups, except those aged more than 51 years, females were more frequently affected than males. Among females, frequency of UTI was 
more among 21-50 years age group and among males elderly patients were more commonly affected. 
 
Table 3: Antimicrobial susceptibility of uropathogenic Citrobacter isolates 
Antibiotics Sensitive Sensitive(%) 
Ampicillin 3 2.9 
Co –trimoxazole 20 18.5 
Norfloxacin 28 25.9 
Ciprofloxacin 40 37 
Gentamicin 25 23.1 
Nalidixic acid 10 9.26 
Amoxyclav 8 7.41 
Amikacin 51 47.2 
Cephalexin 8 7.41 
Cefoparazone –salbactam 35 32.4 
Piperacillin-tazobactum 59 54.6 
Ofloxacin 46 42.6 
Nitrofurantoin 39 36.1 
The most active antimicrobial agent against Citrobacter isolates were piperacillin-tazobactum (55% sensitive), closely followed by amikacin (47 %). 
Amikacin was more effective aminoglycoside than others. Least active antibiotics were ampicillin (3%) and cephalexin.(7%)  
 
Majority of the isolates showed multidrug resistence in the current 
study and were found to be resistant to cephalaxin, norfloxacin, 
ciprofloxacin, and the aminoglycosides [Table 3]. This has important 
implications as patients in a tertiary care hospital like ours receive 
cephalosoprins, aminoglycosides, fluoroquinolone, or a combination 
of these drugs as empirical therapy or as definitive treatment. Since 
good in vitro activity was shown by piperacillin-tazobactum it may 
be considered as first line therapy for ambulatory patients. The high 
rates of antibiotic resistance observed in the present study may be 
due to the fact that ours is a tertiary care hospital with widespread 
usage of broad spectrum antibiotics leading to selective survival 
advantage of pathogens. 
In our study, most of the isolates were from inpatients, similar 
observations have been made by previous studies [14,17], the 
probable reason for this are as follows. The hospital staff carry the 
bacterium in their hands and gastrointestinal systems and invasive 
procedures like catheterization helps these organisms to colonize 
urinary bladder [13,14]. 
CONCLUSION 
The Citrobacter isolates resistant to multiple anti-microbial agents 
have emerged, making it an emerging nosocomial pathogen. The 
emergence of this usually rare organism as the third most common 
urinary pathogen, which is resistant to commonly available 
Basavaraj et al. 
Int J Pharm Pharm Sci, Vol 7, Issue 1, 252-254 
254 
antibiotics is alarming. The indiscriminate use of antimicrobial 
agents is possibly the main reason responsible for this situation. 
Therefore, such studies will guide clinicians to choose accurate 
empirical treatment options and will help to reduce the mortality 
and morbidity rates from infections. It is more significant to prevent 
the resistance development in micro-organisms and to lend the 
accurate information to clinicians in terms of the use of antibiotics in 
appropriate period. 
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